Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CDâ19 chimeric antigen receptor Tâcell therapy
Tambaro, Francesco Paolo, Khazal, Sajad, Nunez, Cesar, Ragoonanan, Dristhi, Tewari, Priti, Petropoulos, Demetrios, Kebriaei, Partow, Wierda, William George, Mahadeo, Kris MichaelJournal:
Clinical Case Reports
DOI:
10.1002/ccr3.2918
Date:
May, 2020
File:
PDF, 252 KB
2020